It is demonstrated that cinnamaldehyde protects against LPS-induced acute lung injury by suppressing excessive NET formation, highlighting NET inhibition as a key mechanism underlying its pulmonary protective effects.
Abstract
Background
Excessive neutrophil activation and neutrophil extracellular trap (NET) formation play critical roles in the pathogenesis of acute lung injury (ALI). Cinnamaldehyde, a major bioactive component of cinnamon, has been reported to exert anti-inflammatory effects; however, its impact on NET formation in ALI remains unclear.
Methods
A lipopolysaccharide (LPS)-induced ALI rat model and a PMA-stimulated primary neutrophil model were employed to evaluate the effects of cinnamaldehyde in vivo and in vitro. Lung injury severity, pulmonary edema, inflammatory cell infiltration, cytokine production, and NET-associated markers were assessed using histopathology, wet-to-dry ratio analysis, BALF examination, immunofluorescence staining, and Western blotting.
Results
Cinnamaldehyde significantly alleviated LPS-induced lung injury, as evidenced by reduced lung wet-to-dry ratios and improved histopathological scores compared with the LPS group (p < .001). Treatment with cinnamaldehyde markedly decreased inflammatory cell and neutrophil infiltration in BALF and suppressed TNF-α, IL-6, and MCP-1 levels (p < .05-0.001). Furthermore, cinnamaldehyde significantly inhibited NET formation in lung tissues, as indicated by reduced levels of myeloperoxidase, cell-free DNA, citrullinated histone H3, and neutrophil elastase (p < .001). In vitro, cinnamaldehyde directly suppressed PMA-induced NET release from primary neutrophils without affecting cell viability (p < .001).
Conclusion
These findings demonstrate that cinnamaldehyde protects against LPS-induced acute lung injury by suppressing excessive NET formation, highlighting NET inhibition as a key mechanism underlying its pulmonary protective effects.
Acute lung injury (ALI) is a life-threatening inflammatory syndrome with limited pharmacological treatment options. Kumatakenin, a plant-derived flavonoid with recognized anti-inflammatory potential, has not been explored in inflammatory lung injury. Here, we investigated the protective effect of Kumatakenin in lipopol...
Dongmei Hai, Xiao-Yun Zhu, Sai-Ya Ye et al.· International Immunopharmaco...· 0 citations
SJS attenuated LPS-induced ALI and restrained neutrophil activation and NET formation mediated by C5a/C5aR1 signaling, and Ferulic acid was identified as a candidate circulating constituent that reduced C5a-activated NET formation.
Dan Zhang, Xin-Xin Li, Jia Zeng et al.· Frontiers in Pharmacology· 0 citations
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening conditions with high mortality. Excessive neutrophil activation and neutrophil extracellular trap (NET)-related responses, together with pulmonary endothelial barrier impairment, are critical pathological features. Heat shock pr...
Wei-Fang Wu, Yu-Shan Lin, Yi-Ze Bian et al.· International Immunopharmaco...· 0 citations
Background: Acute lung injury (ALI) is a severe inflammatory lung condition characterized by alveolar damage, barrier disruption, and excessive inflammation. Current therapeutic strategies remain limited, highlighting the need for novel therapeutic targets. Dysregulated nuclear factor kappa B (NF-κB) and mitogen-activa...
Acute lung injury (ALI) or its more severe form, acute respiratory distress syndrome, is a life-threatening disease closely associated with an imbalance of M1/M2 macrophage polarization. Dezocine is commonly used clinically for perioperative pain relief, but whether it can regulate lipopolysaccharide (LPS)-induced alve...
Zhen-Zhen Liu, Man Feng, Zi-Qiang Qiu et al.· European Journal of Pharmaco...· 0 citations
Sepsis-associated acute lung injury (SALI) is a critical complication of sepsis, characterized by alveolar epithelial barrier disruption and excessive inflammation, which contributes substantially to morbidity and mortality. The present study investigates the protective effects of ginsenoside Rb1 on SALI and elucidates...
Ming Hao, Yun-Yan Zhang, Liu Chen et al.· International Immunopharmaco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.